| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Encephalomyelitis, Autoimmune, Experimental | 25 | 2021 | 133 | 7.090 |
Why?
|
| S-Nitrosoglutathione | 28 | 2021 | 87 | 7.020 |
Why?
|
| Adrenoleukodystrophy | 29 | 2016 | 45 | 6.030 |
Why?
|
| Fatty Acids | 47 | 2015 | 222 | 4.120 |
Why?
|
| Lovastatin | 22 | 2018 | 78 | 4.110 |
Why?
|
| Microbodies | 41 | 1998 | 60 | 3.860 |
Why?
|
| Peroxisomes | 19 | 2019 | 48 | 3.730 |
Why?
|
| Neuroprotective Agents | 25 | 2020 | 317 | 3.370 |
Why?
|
| Rats | 126 | 2016 | 5300 | 3.270 |
Why?
|
| Animals | 192 | 2021 | 20881 | 3.140 |
Why?
|
| Nitric Oxide | 26 | 2019 | 382 | 3.050 |
Why?
|
| Nitric Oxide Synthase | 24 | 2005 | 163 | 2.920 |
Why?
|
| Nitric Oxide Donors | 9 | 2018 | 54 | 2.900 |
Why?
|
| Oligodendroglia | 19 | 2015 | 107 | 2.900 |
Why?
|
| Astrocytes | 22 | 2015 | 270 | 2.870 |
Why?
|
| Alcohol Dehydrogenase | 4 | 2021 | 32 | 2.730 |
Why?
|
| Pyrroles | 7 | 2021 | 83 | 2.720 |
Why?
|
| Inflammation | 21 | 2021 | 1030 | 2.440 |
Why?
|
| Rats, Sprague-Dawley | 64 | 2018 | 2083 | 2.330 |
Why?
|
| Brain | 37 | 2020 | 2176 | 2.320 |
Why?
|
| Benzamides | 6 | 2021 | 156 | 2.270 |
Why?
|
| Enzyme Inhibitors | 24 | 2021 | 659 | 2.230 |
Why?
|
| Cytokines | 29 | 2021 | 866 | 2.230 |
Why?
|
| Disease Models, Animal | 44 | 2020 | 2550 | 2.160 |
Why?
|
| Acetylcysteine | 23 | 2017 | 296 | 2.110 |
Why?
|
| Lipopolysaccharides | 28 | 2016 | 455 | 2.110 |
Why?
|
| Oxidation-Reduction | 48 | 2018 | 567 | 2.100 |
Why?
|
| Blood-Brain Barrier | 11 | 2021 | 99 | 2.100 |
Why?
|
| Neuroglia | 19 | 2014 | 136 | 2.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 15 | 2016 | 212 | 2.000 |
Why?
|
| Liver | 28 | 2019 | 1118 | 1.960 |
Why?
|
| Cells, Cultured | 56 | 2018 | 2673 | 1.910 |
Why?
|
| Multiple Sclerosis | 9 | 2021 | 132 | 1.860 |
Why?
|
| AMP-Activated Protein Kinases | 12 | 2018 | 48 | 1.780 |
Why?
|
| Coenzyme A Ligases | 19 | 2006 | 25 | 1.740 |
Why?
|
| Oxidative Stress | 19 | 2015 | 718 | 1.710 |
Why?
|
| Recovery of Function | 9 | 2021 | 506 | 1.680 |
Why?
|
| Nitric Oxide Synthase Type II | 30 | 2016 | 201 | 1.660 |
Why?
|
| Spinal Cord Injuries | 10 | 2021 | 551 | 1.620 |
Why?
|
| STAT3 Transcription Factor | 4 | 2017 | 86 | 1.610 |
Why?
|
| Mice | 54 | 2021 | 8474 | 1.600 |
Why?
|
| Catalase | 20 | 2006 | 85 | 1.590 |
Why?
|
| ATP-Binding Cassette Transporters | 8 | 2015 | 120 | 1.570 |
Why?
|
| Brain Injuries | 8 | 2017 | 268 | 1.480 |
Why?
|
| PPAR alpha | 8 | 2019 | 31 | 1.430 |
Why?
|
| Multienzyme Complexes | 9 | 2013 | 50 | 1.410 |
Why?
|
| NF-kappa B | 24 | 2018 | 432 | 1.370 |
Why?
|
| Peroxisomal Disorders | 9 | 2009 | 16 | 1.350 |
Why?
|
| Infarction, Middle Cerebral Artery | 7 | 2019 | 105 | 1.330 |
Why?
|
| Signal Transduction | 20 | 2019 | 2689 | 1.320 |
Why?
|
| Leukodystrophy, Globoid Cell | 10 | 2016 | 27 | 1.280 |
Why?
|
| Fibroblasts | 29 | 2015 | 902 | 1.270 |
Why?
|
| Peroxynitrous Acid | 6 | 2018 | 55 | 1.230 |
Why?
|
| Central Nervous System | 6 | 2013 | 107 | 1.220 |
Why?
|
| Mice, Inbred C57BL | 22 | 2021 | 2791 | 1.220 |
Why?
|
| Phytanic Acid | 11 | 2002 | 11 | 1.220 |
Why?
|
| Saccharomyces cerevisiae Proteins | 11 | 2000 | 123 | 1.180 |
Why?
|
| Repressor Proteins | 11 | 2000 | 183 | 1.180 |
Why?
|
| Aminoimidazole Carboxamide | 8 | 2018 | 25 | 1.170 |
Why?
|
| Ribonucleotides | 8 | 2018 | 26 | 1.130 |
Why?
|
| Mitochondria | 18 | 2018 | 643 | 1.120 |
Why?
|
| rho-Associated Kinases | 4 | 2018 | 32 | 1.080 |
Why?
|
| rhoA GTP-Binding Protein | 5 | 2018 | 37 | 1.070 |
Why?
|
| Interferon-gamma | 8 | 2018 | 241 | 1.070 |
Why?
|
| Zellweger Syndrome | 12 | 2004 | 14 | 1.070 |
Why?
|
| Th1 Cells | 9 | 2018 | 101 | 1.070 |
Why?
|
| Interleukin-17 | 3 | 2018 | 62 | 1.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 20 | 2016 | 626 | 1.040 |
Why?
|
| Lymphocytes | 2 | 2021 | 228 | 1.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 6 | 2021 | 226 | 0.960 |
Why?
|
| Arginine | 3 | 2021 | 102 | 0.950 |
Why?
|
| Autoimmune Diseases | 2 | 2021 | 186 | 0.940 |
Why?
|
| Aldehyde Dehydrogenase, Mitochondrial | 2 | 2021 | 21 | 0.930 |
Why?
|
| Skin | 16 | 2011 | 451 | 0.930 |
Why?
|
| Cell Line | 29 | 2018 | 1752 | 0.910 |
Why?
|
| Neurons | 12 | 2018 | 881 | 0.890 |
Why?
|
| Superoxide Dismutase | 14 | 2018 | 149 | 0.880 |
Why?
|
| Reperfusion Injury | 14 | 2015 | 320 | 0.870 |
Why?
|
| Stroke | 7 | 2020 | 2163 | 0.870 |
Why?
|
| Hydroxamic Acids | 2 | 2015 | 84 | 0.860 |
Why?
|
| Th17 Cells | 2 | 2021 | 116 | 0.850 |
Why?
|
| Spinal Cord | 9 | 2018 | 244 | 0.840 |
Why?
|
| Transcription Factors | 10 | 2006 | 753 | 0.840 |
Why?
|
| Gene Expression Regulation | 10 | 2018 | 1293 | 0.830 |
Why?
|
| Lactosylceramides | 3 | 2007 | 27 | 0.780 |
Why?
|
| Humans | 97 | 2021 | 68618 | 0.780 |
Why?
|
| Stem Cells | 6 | 2011 | 248 | 0.770 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2021 | 16 | 0.770 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2013 | 19 | 0.750 |
Why?
|
| Reactive Oxygen Species | 14 | 2013 | 499 | 0.750 |
Why?
|
| Gene Expression Regulation, Enzymologic | 8 | 2010 | 282 | 0.740 |
Why?
|
| Nitric Oxide Synthase Type I | 4 | 2018 | 35 | 0.740 |
Why?
|
| Myeloid Cells | 1 | 2021 | 57 | 0.730 |
Why?
|
| Models, Biological | 9 | 2015 | 981 | 0.720 |
Why?
|
| Male | 66 | 2021 | 37321 | 0.710 |
Why?
|
| Hypoxia | 1 | 2021 | 169 | 0.710 |
Why?
|
| Apoptosis | 20 | 2017 | 1641 | 0.700 |
Why?
|
| Kidney | 15 | 2016 | 945 | 0.700 |
Why?
|
| Organelle Biogenesis | 1 | 2019 | 34 | 0.690 |
Why?
|
| Animals, Newborn | 13 | 2017 | 396 | 0.690 |
Why?
|
| Cell Proliferation | 10 | 2017 | 1174 | 0.690 |
Why?
|
| Interleukin-10 | 3 | 2018 | 144 | 0.690 |
Why?
|
| Cell Differentiation | 11 | 2021 | 1034 | 0.690 |
Why?
|
| Premature Birth | 2 | 2012 | 150 | 0.680 |
Why?
|
| Female | 52 | 2021 | 38074 | 0.680 |
Why?
|
| Psychosine | 9 | 2016 | 33 | 0.670 |
Why?
|
| Adoptive Transfer | 2 | 2018 | 100 | 0.670 |
Why?
|
| Brain Ischemia | 7 | 2017 | 665 | 0.670 |
Why?
|
| Antioxidants | 15 | 2018 | 304 | 0.670 |
Why?
|
| Membrane Microdomains | 2 | 2010 | 32 | 0.670 |
Why?
|
| Caffeic Acids | 3 | 2018 | 9 | 0.660 |
Why?
|
| Phenylethyl Alcohol | 3 | 2018 | 9 | 0.660 |
Why?
|
| Simvastatin | 2 | 2012 | 34 | 0.660 |
Why?
|
| Antineoplastic Agents | 4 | 2015 | 1070 | 0.650 |
Why?
|
| Phosphorylation | 11 | 2015 | 1200 | 0.650 |
Why?
|
| Myelin Sheath | 7 | 2013 | 115 | 0.640 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2019 | 87 | 0.640 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2019 | 102 | 0.640 |
Why?
|
| RNA, Messenger | 17 | 2011 | 1664 | 0.640 |
Why?
|
| Neoplasm Proteins | 4 | 2015 | 307 | 0.630 |
Why?
|
| Heptanoic Acids | 3 | 2008 | 28 | 0.630 |
Why?
|
| Immunomodulation | 1 | 2018 | 35 | 0.620 |
Why?
|
| Cell Survival | 9 | 2015 | 901 | 0.610 |
Why?
|
| Rats, Inbred Lew | 12 | 2013 | 150 | 0.610 |
Why?
|
| X Chromosome | 8 | 2000 | 28 | 0.600 |
Why?
|
| Cyclic AMP | 5 | 2009 | 223 | 0.600 |
Why?
|
| Subcellular Fractions | 13 | 2006 | 92 | 0.600 |
Why?
|
| Free Radical Scavengers | 6 | 2011 | 112 | 0.590 |
Why?
|
| Mice, Knockout | 11 | 2021 | 1692 | 0.590 |
Why?
|
| Inflammation Mediators | 8 | 2016 | 244 | 0.590 |
Why?
|
| Nerve Regeneration | 3 | 2015 | 42 | 0.580 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2018 | 199 | 0.570 |
Why?
|
| Amyloid beta-Peptides | 3 | 2015 | 191 | 0.570 |
Why?
|
| Tyrosine | 6 | 2018 | 196 | 0.550 |
Why?
|
| Arachidonate 5-Lipoxygenase | 3 | 2015 | 14 | 0.550 |
Why?
|
| PPAR gamma | 4 | 2013 | 95 | 0.550 |
Why?
|
| Ceramides | 5 | 2004 | 578 | 0.540 |
Why?
|
| Intracellular Membranes | 4 | 2006 | 86 | 0.520 |
Why?
|
| Arachidonic Acids | 2 | 2015 | 97 | 0.520 |
Why?
|
| Adenylate Kinase | 1 | 2015 | 10 | 0.520 |
Why?
|
| Polyradiculopathy | 1 | 2015 | 6 | 0.510 |
Why?
|
| Endothelial Cells | 8 | 2018 | 384 | 0.510 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2015 | 63 | 0.510 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2013 | 116 | 0.500 |
Why?
|
| Amyloid beta-Protein Precursor | 3 | 2020 | 115 | 0.500 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2010 | 49 | 0.500 |
Why?
|
| Mevalonic Acid | 6 | 2012 | 27 | 0.500 |
Why?
|
| Gene Deletion | 2 | 2015 | 235 | 0.500 |
Why?
|
| Endotoxins | 5 | 2000 | 76 | 0.490 |
Why?
|
| Gene Expression Profiling | 3 | 2016 | 498 | 0.490 |
Why?
|
| Sphingomyelin Phosphodiesterase | 3 | 2004 | 183 | 0.490 |
Why?
|
| Vitamin E | 2 | 2004 | 55 | 0.480 |
Why?
|
| Proline | 2 | 2005 | 52 | 0.480 |
Why?
|
| Sphingomyelins | 4 | 2010 | 106 | 0.480 |
Why?
|
| Cisplatin | 1 | 2015 | 192 | 0.480 |
Why?
|
| Urinary Bladder Diseases | 1 | 2014 | 26 | 0.470 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 86 | 0.470 |
Why?
|
| Enzyme Activation | 10 | 2016 | 791 | 0.470 |
Why?
|
| Aging | 1 | 2020 | 911 | 0.470 |
Why?
|
| Blotting, Western | 11 | 2014 | 954 | 0.450 |
Why?
|
| Antigens, CD | 2 | 2005 | 230 | 0.450 |
Why?
|
| Gene Silencing | 2 | 2011 | 137 | 0.450 |
Why?
|
| Ischemia | 8 | 2003 | 229 | 0.450 |
Why?
|
| Anticholesteremic Agents | 3 | 2005 | 49 | 0.440 |
Why?
|
| Lysine | 1 | 2013 | 96 | 0.440 |
Why?
|
| Oxygen | 3 | 2002 | 386 | 0.440 |
Why?
|
| Random Allocation | 9 | 2017 | 442 | 0.440 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2012 | 5 | 0.430 |
Why?
|
| Cauda Equina | 1 | 2012 | 3 | 0.430 |
Why?
|
| Refsum Disease | 4 | 1998 | 4 | 0.430 |
Why?
|
| Spinal Stenosis | 1 | 2012 | 12 | 0.430 |
Why?
|
| Oxidoreductases | 5 | 2010 | 117 | 0.420 |
Why?
|
| Spinal Cord Compression | 1 | 2012 | 23 | 0.420 |
Why?
|
| In Situ Nick-End Labeling | 10 | 2013 | 160 | 0.420 |
Why?
|
| Nervous System Diseases | 2 | 2007 | 142 | 0.420 |
Why?
|
| Contractile Proteins | 1 | 2012 | 17 | 0.420 |
Why?
|
| Anti-Inflammatory Agents | 5 | 2016 | 234 | 0.410 |
Why?
|
| Hypothermia, Induced | 4 | 2017 | 93 | 0.410 |
Why?
|
| Plasmalogens | 4 | 2008 | 8 | 0.410 |
Why?
|
| Immunohistochemistry | 14 | 2013 | 1174 | 0.410 |
Why?
|
| Cell Line, Tumor | 10 | 2017 | 1851 | 0.400 |
Why?
|
| Brain Chemistry | 5 | 2010 | 173 | 0.400 |
Why?
|
| Lipid Peroxidation | 7 | 2011 | 94 | 0.400 |
Why?
|
| Amenorrhea | 1 | 2011 | 16 | 0.400 |
Why?
|
| Hippocampus | 3 | 2018 | 471 | 0.400 |
Why?
|
| Microglia | 5 | 2010 | 143 | 0.390 |
Why?
|
| Interleukin-1 | 7 | 2005 | 86 | 0.390 |
Why?
|
| Transfection | 8 | 2013 | 782 | 0.390 |
Why?
|
| Glutathione | 11 | 2016 | 343 | 0.380 |
Why?
|
| Pregnancy | 8 | 2013 | 2334 | 0.380 |
Why?
|
| Cyclooxygenase 2 | 4 | 2015 | 160 | 0.380 |
Why?
|
| Biomarkers | 7 | 2018 | 1593 | 0.380 |
Why?
|
| Benzodioxoles | 2 | 2021 | 30 | 0.370 |
Why?
|
| MicroRNAs | 1 | 2016 | 447 | 0.370 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 4 | 2012 | 134 | 0.370 |
Why?
|
| Macrophages | 3 | 2009 | 647 | 0.370 |
Why?
|
| Dose-Response Relationship, Drug | 15 | 2016 | 1745 | 0.370 |
Why?
|
| Palmitic Acids | 9 | 1993 | 15 | 0.370 |
Why?
|
| Fetal Diseases | 1 | 2011 | 64 | 0.360 |
Why?
|
| Myelin Proteolipid Protein | 7 | 2010 | 20 | 0.360 |
Why?
|
| Encephalitis | 3 | 2008 | 43 | 0.360 |
Why?
|
| Neoplasms | 2 | 2015 | 1667 | 0.360 |
Why?
|
| Calcitriol | 3 | 2017 | 106 | 0.360 |
Why?
|
| Uterus | 2 | 2012 | 77 | 0.360 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 629 | 0.350 |
Why?
|
| Child | 10 | 2016 | 6405 | 0.350 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2012 | 331 | 0.350 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 3 | 2021 | 17 | 0.350 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2010 | 108 | 0.350 |
Why?
|
| Head and Neck Neoplasms | 1 | 2015 | 561 | 0.340 |
Why?
|
| Phospholipases A | 3 | 2006 | 41 | 0.340 |
Why?
|
| Brain Edema | 4 | 2019 | 50 | 0.330 |
Why?
|
| Adenosine Triphosphate | 6 | 2018 | 314 | 0.330 |
Why?
|
| Hypoxia-Ischemia, Brain | 3 | 2017 | 56 | 0.330 |
Why?
|
| Down-Regulation | 9 | 2012 | 447 | 0.330 |
Why?
|
| Trans-Activators | 3 | 2005 | 237 | 0.330 |
Why?
|
| Vitamin D | 2 | 2017 | 516 | 0.330 |
Why?
|
| Immunologic Factors | 3 | 2009 | 87 | 0.330 |
Why?
|
| Analysis of Variance | 7 | 2015 | 1040 | 0.330 |
Why?
|
| Clofibric Acid | 6 | 1996 | 12 | 0.320 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2009 | 154 | 0.320 |
Why?
|
| Chemokine CCL22 | 1 | 2008 | 6 | 0.320 |
Why?
|
| Brain Diseases | 1 | 2009 | 78 | 0.320 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2008 | 57 | 0.320 |
Why?
|
| Demyelinating Diseases | 6 | 2016 | 57 | 0.320 |
Why?
|
| Gene Expression | 4 | 2018 | 770 | 0.320 |
Why?
|
| Lipids | 4 | 2018 | 298 | 0.320 |
Why?
|
| Cerebrum | 1 | 2008 | 20 | 0.310 |
Why?
|
| Phospholipids | 1 | 2008 | 108 | 0.310 |
Why?
|
| Matrix Metalloproteinase 9 | 4 | 2014 | 160 | 0.310 |
Why?
|
| Phenylacetates | 2 | 1998 | 18 | 0.310 |
Why?
|
| Mitochondria, Liver | 6 | 1994 | 148 | 0.310 |
Why?
|
| Enoyl-CoA Hydratase | 2 | 2006 | 3 | 0.310 |
Why?
|
| Isomerases | 2 | 2006 | 4 | 0.310 |
Why?
|
| 3-Hydroxyacyl CoA Dehydrogenases | 2 | 2006 | 5 | 0.310 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2006 | 19 | 0.300 |
Why?
|
| Second Messenger Systems | 1 | 2007 | 53 | 0.300 |
Why?
|
| Uveitis | 1 | 2007 | 13 | 0.290 |
Why?
|
| Enzyme Induction | 6 | 2005 | 119 | 0.290 |
Why?
|
| Membrane Proteins | 6 | 2018 | 617 | 0.290 |
Why?
|
| Macrophages, Peritoneal | 4 | 2004 | 67 | 0.290 |
Why?
|
| Polyethylene Glycols | 1 | 2008 | 149 | 0.280 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2018 | 105 | 0.280 |
Why?
|
| Administration, Oral | 5 | 2015 | 411 | 0.280 |
Why?
|
| Peptide Fragments | 6 | 2015 | 483 | 0.280 |
Why?
|
| Lipoxygenase | 2 | 2006 | 13 | 0.280 |
Why?
|
| Diffuse Cerebral Sclerosis of Schilder | 4 | 1990 | 15 | 0.280 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2004 | 66 | 0.280 |
Why?
|
| Cytoprotection | 1 | 2006 | 39 | 0.270 |
Why?
|
| Isoenzymes | 5 | 2010 | 308 | 0.270 |
Why?
|
| Seizures | 1 | 2008 | 279 | 0.270 |
Why?
|
| Wound Healing | 1 | 2008 | 260 | 0.260 |
Why?
|
| Protective Agents | 1 | 2006 | 36 | 0.260 |
Why?
|
| NADH Dehydrogenase | 6 | 2000 | 13 | 0.260 |
Why?
|
| Endothelium, Vascular | 2 | 2020 | 371 | 0.260 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2016 | 71 | 0.260 |
Why?
|
| Rats, Inbred Strains | 14 | 1992 | 532 | 0.260 |
Why?
|
| Glutathione Peroxidase | 7 | 2002 | 39 | 0.260 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2014 | 52 | 0.260 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2005 | 411 | 0.260 |
Why?
|
| Time Factors | 14 | 2016 | 4655 | 0.260 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2010 | 710 | 0.260 |
Why?
|
| Calpain | 5 | 2018 | 205 | 0.250 |
Why?
|
| Adenosine Kinase | 1 | 2005 | 6 | 0.250 |
Why?
|
| Neurodegenerative Diseases | 1 | 2006 | 102 | 0.250 |
Why?
|
| Myelitis | 1 | 2005 | 9 | 0.250 |
Why?
|
| Prostaglandin D2 | 1 | 2004 | 21 | 0.250 |
Why?
|
| tau Proteins | 2 | 2015 | 61 | 0.250 |
Why?
|
| Th2 Cells | 5 | 2010 | 48 | 0.250 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 39 | 0.240 |
Why?
|
| Locomotion | 3 | 2015 | 135 | 0.240 |
Why?
|
| Acyl-CoA Oxidase | 5 | 2011 | 12 | 0.240 |
Why?
|
| Coculture Techniques | 4 | 2010 | 147 | 0.240 |
Why?
|
| Behavior, Animal | 3 | 2019 | 470 | 0.240 |
Why?
|
| Fatty Acids, Monounsaturated | 3 | 2010 | 29 | 0.230 |
Why?
|
| Nerve Tissue Proteins | 2 | 2015 | 290 | 0.230 |
Why?
|
| Hyperalgesia | 2 | 2015 | 18 | 0.230 |
Why?
|
| Adjuvants, Immunologic | 1 | 2004 | 63 | 0.230 |
Why?
|
| Cholesterol | 4 | 2010 | 331 | 0.230 |
Why?
|
| Cell Fractionation | 8 | 2000 | 34 | 0.230 |
Why?
|
| Disease Progression | 3 | 2019 | 1038 | 0.230 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 1447 | 0.230 |
Why?
|
| Cell Membrane | 6 | 2015 | 525 | 0.230 |
Why?
|
| Drug Synergism | 6 | 2018 | 260 | 0.230 |
Why?
|
| Nerve Degeneration | 4 | 2010 | 134 | 0.220 |
Why?
|
| Up-Regulation | 4 | 2010 | 682 | 0.220 |
Why?
|
| Pre-Eclampsia | 1 | 2005 | 202 | 0.220 |
Why?
|
| Blotting, Northern | 6 | 2013 | 189 | 0.220 |
Why?
|
| Cicer | 1 | 2022 | 2 | 0.210 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 271 | 0.210 |
Why?
|
| Sphingolipids | 1 | 2006 | 337 | 0.210 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2013 | 282 | 0.210 |
Why?
|
| Extracellular Matrix | 1 | 2006 | 493 | 0.210 |
Why?
|
| GATA3 Transcription Factor | 3 | 2010 | 6 | 0.210 |
Why?
|
| Thiocarbamates | 5 | 2005 | 20 | 0.210 |
Why?
|
| Acetylation | 2 | 2013 | 94 | 0.210 |
Why?
|
| Amino Acid Sequence | 5 | 2015 | 1083 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2015 | 331 | 0.210 |
Why?
|
| T-Box Domain Proteins | 4 | 2006 | 29 | 0.210 |
Why?
|
| Acetyltransferases | 2 | 2013 | 49 | 0.210 |
Why?
|
| Glial Fibrillary Acidic Protein | 4 | 2012 | 92 | 0.200 |
Why?
|
| Rolipram | 3 | 2009 | 9 | 0.200 |
Why?
|
| Galactosylceramidase | 3 | 2016 | 11 | 0.200 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2013 | 93 | 0.200 |
Why?
|
| Thioridazine | 2 | 1993 | 6 | 0.200 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2018 | 284 | 0.200 |
Why?
|
| Pertussis Toxin | 1 | 2021 | 72 | 0.190 |
Why?
|
| Cerebral Cortex | 3 | 2013 | 415 | 0.190 |
Why?
|
| Cellular Microenvironment | 1 | 2021 | 10 | 0.190 |
Why?
|
| Connexin 43 | 2 | 2012 | 62 | 0.190 |
Why?
|
| Metformin | 2 | 2013 | 63 | 0.190 |
Why?
|
| Monocytes | 3 | 2007 | 210 | 0.190 |
Why?
|
| Aldehydes | 1 | 2021 | 34 | 0.190 |
Why?
|
| Cell Death | 5 | 2016 | 329 | 0.190 |
Why?
|
| Genetic Linkage | 6 | 1998 | 90 | 0.190 |
Why?
|
| Morpholines | 4 | 2012 | 79 | 0.190 |
Why?
|
| Biological Transport | 6 | 1998 | 210 | 0.180 |
Why?
|
| Drug Therapy, Combination | 6 | 2015 | 649 | 0.180 |
Why?
|
| Polyisoprenyl Phosphates | 3 | 2008 | 8 | 0.180 |
Why?
|
| Rhinovirus | 4 | 2002 | 15 | 0.180 |
Why?
|
| Coenzyme A | 3 | 1996 | 4 | 0.180 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2015 | 175 | 0.180 |
Why?
|
| RNA, Small Interfering | 4 | 2010 | 434 | 0.180 |
Why?
|
| 3' Untranslated Regions | 1 | 2000 | 56 | 0.180 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2015 | 126 | 0.180 |
Why?
|
| Salmonella typhimurium | 2 | 2000 | 15 | 0.180 |
Why?
|
| Protein Biosynthesis | 2 | 2000 | 181 | 0.180 |
Why?
|
| Cell Adhesion Molecules | 3 | 2018 | 199 | 0.180 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2013 | 67 | 0.170 |
Why?
|
| Vitamin D3 24-Hydroxylase | 3 | 2017 | 24 | 0.170 |
Why?
|
| DNA Primers | 4 | 2011 | 302 | 0.170 |
Why?
|
| Alzheimer Disease | 3 | 2018 | 565 | 0.170 |
Why?
|
| Drug Delivery Systems | 2 | 2020 | 236 | 0.170 |
Why?
|
| Imidazoles | 3 | 2007 | 175 | 0.170 |
Why?
|
| Chromosome Mapping | 3 | 1998 | 188 | 0.170 |
Why?
|
| Palmitic Acid | 6 | 2000 | 51 | 0.170 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 329 | 0.170 |
Why?
|
| Cerebrovascular Disorders | 1 | 2020 | 182 | 0.160 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2019 | 114 | 0.160 |
Why?
|
| Hydrogen Peroxide | 6 | 2002 | 168 | 0.160 |
Why?
|
| Nervous System | 2 | 2016 | 45 | 0.160 |
Why?
|
| DNA-Binding Proteins | 3 | 2011 | 700 | 0.160 |
Why?
|
| Transcription, Genetic | 3 | 2000 | 562 | 0.160 |
Why?
|
| Chemotaxis, Leukocyte | 4 | 2007 | 48 | 0.160 |
Why?
|
| Nitrosoguanidines | 1 | 2018 | 4 | 0.160 |
Why?
|
| Tight Junction Proteins | 1 | 2018 | 1 | 0.160 |
Why?
|
| Mixed Function Oxygenases | 1 | 1998 | 35 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 5 | 2007 | 852 | 0.160 |
Why?
|
| Protein S | 1 | 2018 | 9 | 0.160 |
Why?
|
| RNA-Binding Proteins | 1 | 2000 | 215 | 0.160 |
Why?
|
| Interleukin-1beta | 2 | 2009 | 88 | 0.160 |
Why?
|
| Nitrites | 3 | 2012 | 53 | 0.150 |
Why?
|
| Lysosomes | 2 | 2016 | 136 | 0.150 |
Why?
|
| GABAergic Neurons | 1 | 2018 | 17 | 0.150 |
Why?
|
| Centrifugation, Density Gradient | 5 | 2002 | 36 | 0.150 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1998 | 67 | 0.150 |
Why?
|
| Spleen | 3 | 2009 | 301 | 0.150 |
Why?
|
| Guanylate Cyclase | 1 | 2018 | 25 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2017 | 304 | 0.150 |
Why?
|
| Growth Inhibitors | 2 | 2011 | 33 | 0.150 |
Why?
|
| Fibric Acids | 6 | 1996 | 12 | 0.150 |
Why?
|
| Interleukin-6 | 2 | 2015 | 330 | 0.150 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2018 | 167 | 0.150 |
Why?
|
| Electron Transport Complex IV | 4 | 2000 | 33 | 0.150 |
Why?
|
| Microscopy, Electron | 6 | 2013 | 351 | 0.150 |
Why?
|
| Glioma | 3 | 2005 | 140 | 0.150 |
Why?
|
| Sphingosine | 1 | 1999 | 315 | 0.150 |
Why?
|
| Mice, Nude | 2 | 2015 | 294 | 0.150 |
Why?
|
| Lysophosphatidylcholines | 2 | 2015 | 11 | 0.150 |
Why?
|
| Sulfonamides | 1 | 1998 | 141 | 0.140 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2006 | 223 | 0.140 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2017 | 61 | 0.140 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 176 | 0.140 |
Why?
|
| Interleukin-8 | 4 | 2002 | 71 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2012 | 2223 | 0.140 |
Why?
|
| Brain Infarction | 3 | 2016 | 54 | 0.140 |
Why?
|
| Immunoblotting | 5 | 2010 | 254 | 0.140 |
Why?
|
| Acyl Coenzyme A | 3 | 1992 | 6 | 0.140 |
Why?
|
| Colforsin | 3 | 2004 | 42 | 0.140 |
Why?
|
| Chondrodysplasia Punctata, Rhizomelic | 1 | 1996 | 1 | 0.140 |
Why?
|
| Arachidonic Acid | 4 | 2006 | 86 | 0.140 |
Why?
|
| Hyperglycemia | 1 | 2018 | 158 | 0.140 |
Why?
|
| Organelles | 2 | 1993 | 18 | 0.140 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2018 | 195 | 0.140 |
Why?
|
| Palmitoyl Coenzyme A | 3 | 1992 | 11 | 0.140 |
Why?
|
| Endoplasmic Reticulum | 3 | 2011 | 148 | 0.140 |
Why?
|
| Glycoproteins | 2 | 2010 | 238 | 0.140 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2014 | 21 | 0.140 |
Why?
|
| Epoxide Hydrolases | 1 | 1996 | 8 | 0.130 |
Why?
|
| Ketoconazole | 1 | 1995 | 6 | 0.130 |
Why?
|
| Hypertension | 1 | 2005 | 1535 | 0.130 |
Why?
|
| Multiple Myeloma | 1 | 2017 | 92 | 0.130 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 40 | 0.130 |
Why?
|
| Drug Interactions | 4 | 2007 | 289 | 0.130 |
Why?
|
| Lymphocyte Count | 1 | 2015 | 53 | 0.130 |
Why?
|
| Cell Nucleus | 3 | 2005 | 305 | 0.130 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2015 | 24 | 0.130 |
Why?
|
| Neural Stem Cells | 1 | 2015 | 32 | 0.130 |
Why?
|
| Capillary Permeability | 1 | 2015 | 69 | 0.130 |
Why?
|
| Organ Preservation Solutions | 2 | 2004 | 45 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1995 | 15 | 0.130 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2012 | 35 | 0.130 |
Why?
|
| Organ Preservation | 2 | 2004 | 69 | 0.130 |
Why?
|
| In Vitro Techniques | 4 | 2007 | 765 | 0.130 |
Why?
|
| Cricetulus | 1 | 2015 | 98 | 0.130 |
Why?
|
| Chromones | 3 | 2012 | 33 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 3 | 2007 | 492 | 0.130 |
Why?
|
| ras Proteins | 2 | 2008 | 102 | 0.130 |
Why?
|
| Nociception | 1 | 2015 | 5 | 0.130 |
Why?
|
| Leukotriene B4 | 1 | 2015 | 17 | 0.130 |
Why?
|
| CHO Cells | 1 | 2015 | 161 | 0.130 |
Why?
|
| Acyltransferases | 4 | 2007 | 40 | 0.130 |
Why?
|
| Gamma Rays | 1 | 2015 | 64 | 0.130 |
Why?
|
| Neoplasms, Experimental | 2 | 2006 | 118 | 0.130 |
Why?
|
| Age Factors | 3 | 2016 | 1864 | 0.130 |
Why?
|
| Proteolysis | 1 | 2015 | 97 | 0.130 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2005 | 60 | 0.130 |
Why?
|
| Binding Sites | 4 | 2006 | 631 | 0.130 |
Why?
|
| Chondrodysplasia Punctata | 2 | 1993 | 2 | 0.120 |
Why?
|
| Mice, Transgenic | 5 | 2020 | 1033 | 0.120 |
Why?
|
| Microsomes | 3 | 1990 | 31 | 0.120 |
Why?
|
| 2',3'-Cyclic-Nucleotide Phosphodiesterases | 5 | 2004 | 18 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2015 | 132 | 0.120 |
Why?
|
| Leupeptins | 2 | 2005 | 23 | 0.120 |
Why?
|
| Galactosyltransferases | 2 | 2005 | 7 | 0.120 |
Why?
|
| Reference Values | 4 | 2000 | 579 | 0.120 |
Why?
|
| Lipid Metabolism | 5 | 2013 | 186 | 0.120 |
Why?
|
| Rats, Wistar | 2 | 2006 | 371 | 0.120 |
Why?
|
| Molecular Weight | 2 | 2006 | 358 | 0.120 |
Why?
|
| Receptor, trkB | 2 | 2012 | 27 | 0.120 |
Why?
|
| Base Sequence | 3 | 2005 | 1015 | 0.120 |
Why?
|
| Cell Hypoxia | 1 | 1995 | 92 | 0.120 |
Why?
|
| Maze Learning | 4 | 2017 | 138 | 0.120 |
Why?
|
| Cell Movement | 3 | 2012 | 630 | 0.120 |
Why?
|
| Lipid Peroxides | 3 | 2000 | 19 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 756 | 0.120 |
Why?
|
| Cystitis | 1 | 2014 | 18 | 0.120 |
Why?
|
| Dinoprostone | 1 | 2015 | 110 | 0.120 |
Why?
|
| Ischemic Attack, Transient | 2 | 2007 | 167 | 0.120 |
Why?
|
| Urination Disorders | 1 | 2014 | 20 | 0.120 |
Why?
|
| Contusions | 1 | 2014 | 11 | 0.120 |
Why?
|
| Reperfusion | 2 | 2012 | 78 | 0.120 |
Why?
|
| Gliosis | 2 | 2005 | 51 | 0.120 |
Why?
|
| Vasodilator Agents | 1 | 2015 | 138 | 0.120 |
Why?
|
| Organ Specificity | 4 | 2008 | 167 | 0.120 |
Why?
|
| I-kappa B Kinase | 2 | 2004 | 40 | 0.120 |
Why?
|
| Urodynamics | 1 | 2014 | 43 | 0.120 |
Why?
|
| Disease | 1 | 2014 | 41 | 0.120 |
Why?
|
| 5'-Nucleotidase | 2 | 1993 | 13 | 0.120 |
Why?
|
| Protein Transport | 2 | 2012 | 280 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 219 | 0.110 |
Why?
|
| Cerulenin | 1 | 2013 | 4 | 0.110 |
Why?
|
| Fatty Acid Synthase, Type I | 1 | 2013 | 5 | 0.110 |
Why?
|
| Phosphoproteins | 2 | 2009 | 202 | 0.110 |
Why?
|
| Proteinuria | 1 | 2014 | 136 | 0.110 |
Why?
|
| Organ Size | 1 | 2014 | 242 | 0.110 |
Why?
|
| Galactosides | 1 | 2013 | 5 | 0.110 |
Why?
|
| Proteins | 1 | 1997 | 474 | 0.110 |
Why?
|
| Urinary Bladder | 1 | 2014 | 108 | 0.110 |
Why?
|
| Case-Control Studies | 2 | 2015 | 1553 | 0.110 |
Why?
|
| Cholecalciferol | 1 | 2014 | 143 | 0.110 |
Why?
|
| Acute Kidney Injury | 1 | 2016 | 232 | 0.110 |
Why?
|
| Sepsis | 1 | 2016 | 233 | 0.110 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2012 | 124 | 0.110 |
Why?
|
| Heart Rate | 1 | 2015 | 568 | 0.110 |
Why?
|
| Cytoplasm | 3 | 2004 | 155 | 0.110 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 2 | 2011 | 17 | 0.110 |
Why?
|
| DNA, Complementary | 2 | 2008 | 251 | 0.110 |
Why?
|
| Central Nervous System Agents | 1 | 2013 | 37 | 0.110 |
Why?
|
| Edema | 2 | 2011 | 66 | 0.110 |
Why?
|
| Glycopeptides | 2 | 2003 | 15 | 0.110 |
Why?
|
| Fatty Liver | 1 | 2013 | 97 | 0.110 |
Why?
|
| Evans Blue | 1 | 2012 | 4 | 0.110 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2012 | 4 | 0.110 |
Why?
|
| Iohexol | 1 | 1993 | 82 | 0.110 |
Why?
|
| Nitroprusside | 2 | 2003 | 42 | 0.110 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2012 | 25 | 0.110 |
Why?
|
| E-Selectin | 1 | 2012 | 44 | 0.110 |
Why?
|
| Steroid Hydroxylases | 1 | 2012 | 19 | 0.110 |
Why?
|
| DNA Fragmentation | 4 | 2006 | 85 | 0.110 |
Why?
|
| Physical Stimulation | 1 | 2012 | 67 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 127 | 0.100 |
Why?
|
| Anthocyanins | 1 | 2012 | 5 | 0.100 |
Why?
|
| Receptors, Oxytocin | 1 | 2012 | 9 | 0.100 |
Why?
|
| Uterine Contraction | 1 | 2012 | 30 | 0.100 |
Why?
|
| Biosynthetic Pathways | 1 | 2012 | 15 | 0.100 |
Why?
|
| Guinea Pigs | 1 | 2012 | 124 | 0.100 |
Why?
|
| Lymphoid Tissue | 1 | 2012 | 30 | 0.100 |
Why?
|
| Biological Availability | 1 | 2012 | 79 | 0.100 |
Why?
|
| Adult | 4 | 2016 | 21403 | 0.100 |
Why?
|
| Salicylates | 2 | 1992 | 22 | 0.100 |
Why?
|
| Cell Compartmentation | 3 | 1998 | 41 | 0.100 |
Why?
|
| Transcriptional Activation | 4 | 2006 | 226 | 0.100 |
Why?
|
| Epoxy Compounds | 3 | 2000 | 20 | 0.100 |
Why?
|
| Adenosine | 3 | 2005 | 165 | 0.100 |
Why?
|
| Postural Balance | 1 | 2012 | 93 | 0.100 |
Why?
|
| Motor Skills | 3 | 2017 | 88 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 306 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1992 | 56 | 0.100 |
Why?
|
| Protein Subunits | 2 | 2009 | 99 | 0.100 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 2009 | 28 | 0.100 |
Why?
|
| Membrane Fluidity | 2 | 2000 | 13 | 0.100 |
Why?
|
| Estrogen Receptor beta | 1 | 2011 | 19 | 0.100 |
Why?
|
| Peroxisomal Bifunctional Enzyme | 2 | 2006 | 4 | 0.100 |
Why?
|
| Estrous Cycle | 1 | 2011 | 23 | 0.100 |
Why?
|
| Motor Activity | 3 | 2015 | 621 | 0.100 |
Why?
|
| Molsidomine | 1 | 2011 | 5 | 0.100 |
Why?
|
| Synaptophysin | 1 | 2011 | 16 | 0.100 |
Why?
|
| Pain Measurement | 1 | 2012 | 328 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2011 | 137 | 0.100 |
Why?
|
| Functional Laterality | 1 | 2012 | 240 | 0.100 |
Why?
|
| Analgesics | 1 | 2012 | 118 | 0.100 |
Why?
|
| Infant, Newborn | 2 | 2015 | 2455 | 0.100 |
Why?
|
| Models, Animal | 1 | 2012 | 252 | 0.100 |
Why?
|
| Lactation | 1 | 1992 | 110 | 0.100 |
Why?
|
| Ovary | 1 | 2011 | 99 | 0.090 |
Why?
|
| Ectodysplasins | 2 | 2008 | 7 | 0.090 |
Why?
|
| Flow Cytometry | 3 | 2007 | 489 | 0.090 |
Why?
|
| Alkyl and Aryl Transferases | 3 | 2006 | 9 | 0.090 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2009 | 93 | 0.090 |
Why?
|
| Histone Deacetylases | 1 | 2011 | 99 | 0.090 |
Why?
|
| Microsomes, Liver | 3 | 2000 | 44 | 0.090 |
Why?
|
| Treatment Outcome | 7 | 2011 | 7029 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2010 | 61 | 0.090 |
Why?
|
| NADPH Oxidases | 2 | 2009 | 80 | 0.090 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2010 | 7 | 0.090 |
Why?
|
| Leukotrienes | 1 | 2010 | 13 | 0.090 |
Why?
|
| Clofibrate | 1 | 1990 | 2 | 0.090 |
Why?
|
| Bone Diseases, Developmental | 1 | 2010 | 15 | 0.090 |
Why?
|
| Cytochrome Reductases | 1 | 1990 | 2 | 0.090 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2010 | 8 | 0.090 |
Why?
|
| STAT Transcription Factors | 1 | 2010 | 13 | 0.090 |
Why?
|
| RNA Interference | 2 | 2013 | 266 | 0.090 |
Why?
|
| Adrenal Glands | 1 | 1990 | 46 | 0.090 |
Why?
|
| Renal Circulation | 1 | 1990 | 49 | 0.090 |
Why?
|
| Antibodies | 3 | 2000 | 241 | 0.090 |
Why?
|
| Caspase 3 | 3 | 2016 | 233 | 0.090 |
Why?
|
| Exercise Therapy | 1 | 2012 | 183 | 0.090 |
Why?
|
| Phospholipases A2, Secretory | 1 | 2009 | 3 | 0.090 |
Why?
|
| Injections, Intraperitoneal | 2 | 2013 | 89 | 0.090 |
Why?
|
| Cognition Disorders | 1 | 2013 | 342 | 0.090 |
Why?
|
| Pyrrolidines | 3 | 1998 | 45 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2012 | 597 | 0.080 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2009 | 84 | 0.080 |
Why?
|
| Virus Replication | 2 | 2000 | 104 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 689 | 0.080 |
Why?
|
| NADPH Oxidase 2 | 1 | 2009 | 16 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 940 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 300 | 0.080 |
Why?
|
| Tetrazolium Salts | 2 | 2006 | 36 | 0.080 |
Why?
|
| Phospholipases A2 | 2 | 2006 | 32 | 0.080 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1988 | 19 | 0.080 |
Why?
|
| T-Lymphocytes | 2 | 2016 | 597 | 0.080 |
Why?
|
| Malondialdehyde | 1 | 2008 | 43 | 0.080 |
Why?
|
| HIV Infections | 1 | 2016 | 791 | 0.080 |
Why?
|
| Myelin Basic Protein | 4 | 2014 | 62 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 196 | 0.080 |
Why?
|
| Genes, Reporter | 2 | 2006 | 191 | 0.080 |
Why?
|
| Kainic Acid | 1 | 2008 | 44 | 0.080 |
Why?
|
| Caspases | 2 | 2006 | 194 | 0.080 |
Why?
|
| Hypoglycemic Agents | 2 | 2006 | 362 | 0.080 |
Why?
|
| In Situ Hybridization | 2 | 2000 | 201 | 0.080 |
Why?
|
| Methionine | 1 | 2008 | 36 | 0.080 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2008 | 17 | 0.080 |
Why?
|
| Glutathione Disulfide | 2 | 2006 | 31 | 0.080 |
Why?
|
| Placenta | 1 | 2008 | 101 | 0.080 |
Why?
|
| Temperature | 2 | 2004 | 341 | 0.070 |
Why?
|
| Necrosis | 2 | 2006 | 239 | 0.070 |
Why?
|
| Nerve Growth Factors | 1 | 2008 | 75 | 0.070 |
Why?
|
| Mice, Neurologic Mutants | 4 | 2010 | 23 | 0.070 |
Why?
|
| Polysaccharides | 1 | 2009 | 176 | 0.070 |
Why?
|
| Pyridines | 2 | 2007 | 261 | 0.070 |
Why?
|
| Mice, Inbred Strains | 2 | 2006 | 181 | 0.070 |
Why?
|
| Retinol-Binding Proteins | 1 | 2007 | 28 | 0.070 |
Why?
|
| Neuropsychological Tests | 1 | 2009 | 517 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2011 | 334 | 0.070 |
Why?
|
| Mice, Mutant Strains | 3 | 2014 | 166 | 0.070 |
Why?
|
| Aspartate Aminotransferases | 2 | 2013 | 87 | 0.070 |
Why?
|
| Autoantibodies | 1 | 1990 | 434 | 0.070 |
Why?
|
| Prodrugs | 1 | 2007 | 54 | 0.070 |
Why?
|
| Electroretinography | 1 | 2007 | 122 | 0.070 |
Why?
|
| Photoreceptor Cells | 1 | 2007 | 62 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 70 | 0.070 |
Why?
|
| Gait Disorders, Neurologic | 2 | 2007 | 86 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2012 | 1851 | 0.070 |
Why?
|
| Cell Line, Transformed | 2 | 2003 | 100 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 320 | 0.070 |
Why?
|
| Receptors, Complement 3d | 1 | 2006 | 45 | 0.070 |
Why?
|
| Reactive Nitrogen Species | 1 | 2006 | 32 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2009 | 370 | 0.070 |
Why?
|
| Receptors, Complement | 1 | 2006 | 58 | 0.070 |
Why?
|
| Blotting, Southern | 1 | 2006 | 67 | 0.070 |
Why?
|
| Eye Proteins | 1 | 2007 | 160 | 0.070 |
Why?
|
| Complement C3 | 1 | 2006 | 101 | 0.070 |
Why?
|
| Gadolinium | 2 | 2004 | 88 | 0.070 |
Why?
|
| Cytosol | 1 | 2006 | 123 | 0.070 |
Why?
|
| Interleukin-4 | 1 | 2006 | 69 | 0.070 |
Why?
|
| Cell Adhesion | 4 | 2007 | 324 | 0.070 |
Why?
|
| Immunologic Memory | 1 | 2006 | 75 | 0.070 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2005 | 16 | 0.070 |
Why?
|
| S Phase | 1 | 2005 | 38 | 0.070 |
Why?
|
| Fetal Weight | 1 | 2005 | 33 | 0.060 |
Why?
|
| Proteome | 1 | 2006 | 87 | 0.060 |
Why?
|
| Thiazoles | 1 | 2006 | 95 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2006 | 156 | 0.060 |
Why?
|
| Alanine Transaminase | 2 | 2013 | 137 | 0.060 |
Why?
|
| Amides | 1 | 2006 | 86 | 0.060 |
Why?
|
| Epithelial Cells | 3 | 2002 | 431 | 0.060 |
Why?
|
| Retina | 1 | 2007 | 252 | 0.060 |
Why?
|
| Complement Activation | 1 | 2006 | 145 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2015 | 64 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 532 | 0.060 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2005 | 48 | 0.060 |
Why?
|
| Research Design | 1 | 2009 | 729 | 0.060 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2004 | 5 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 376 | 0.060 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2004 | 4 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2006 | 420 | 0.060 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2004 | 5 | 0.060 |
Why?
|
| Antigen Presentation | 1 | 2005 | 76 | 0.060 |
Why?
|
| Freund's Adjuvant | 1 | 2004 | 7 | 0.060 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2004 | 14 | 0.060 |
Why?
|
| Cell Communication | 1 | 2005 | 116 | 0.060 |
Why?
|
| Permeability | 1 | 2005 | 131 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 216 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2004 | 69 | 0.060 |
Why?
|
| Proteasome Inhibitors | 1 | 2004 | 29 | 0.060 |
Why?
|
| Genes, MHC Class II | 1 | 2004 | 29 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2006 | 1753 | 0.060 |
Why?
|
| I-kappa B Proteins | 1 | 2004 | 47 | 0.060 |
Why?
|
| Free Radicals | 1 | 2004 | 65 | 0.060 |
Why?
|
| Adenosine Triphosphatases | 1 | 2004 | 83 | 0.060 |
Why?
|
| Microarray Analysis | 1 | 2004 | 63 | 0.060 |
Why?
|
| RNA | 1 | 2005 | 171 | 0.060 |
Why?
|
| Growth Substances | 1 | 2004 | 77 | 0.060 |
Why?
|
| Epithelium | 3 | 1999 | 172 | 0.060 |
Why?
|
| Cell Migration Inhibition | 1 | 2004 | 8 | 0.060 |
Why?
|
| Interphase | 1 | 2004 | 19 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2004 | 74 | 0.060 |
Why?
|
| Proteomics | 1 | 2006 | 246 | 0.060 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2004 | 38 | 0.060 |
Why?
|
| Protein Prenylation | 1 | 2003 | 7 | 0.060 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2004 | 55 | 0.060 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2003 | 10 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2009 | 659 | 0.060 |
Why?
|
| Chronic Disease | 3 | 2015 | 1330 | 0.060 |
Why?
|
| Pipecolic Acids | 2 | 1997 | 9 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2003 | 18 | 0.060 |
Why?
|
| Allopurinol | 3 | 2004 | 36 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 507 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 1173 | 0.060 |
Why?
|
| Protein Binding | 1 | 2006 | 1027 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2014 | 209 | 0.050 |
Why?
|
| Chemokines | 1 | 2003 | 119 | 0.050 |
Why?
|
| Hypolipidemic Agents | 2 | 1994 | 82 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2010 | 231 | 0.050 |
Why?
|
| Glucosyltransferases | 1 | 2022 | 28 | 0.050 |
Why?
|
| Salts | 1 | 2022 | 21 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 1996 | 511 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 248 | 0.050 |
Why?
|
| Soil | 1 | 2022 | 51 | 0.050 |
Why?
|
| Bronchi | 1 | 2002 | 59 | 0.050 |
Why?
|
| Carnitine | 2 | 1994 | 17 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 742 | 0.050 |
Why?
|
| Kidney Transplantation | 2 | 2004 | 839 | 0.050 |
Why?
|
| Kinetics | 2 | 1993 | 1047 | 0.050 |
Why?
|
| Glucose | 1 | 2003 | 307 | 0.050 |
Why?
|
| Superoxides | 2 | 2018 | 70 | 0.050 |
Why?
|
| X-Ray Diffraction | 2 | 1993 | 53 | 0.050 |
Why?
|
| Creatinine | 2 | 2016 | 243 | 0.050 |
Why?
|
| Risk Factors | 3 | 2017 | 5731 | 0.050 |
Why?
|
| Contrast Media | 1 | 2004 | 595 | 0.050 |
Why?
|
| Imidazolines | 1 | 2000 | 1 | 0.050 |
Why?
|
| Genetic Complementation Test | 2 | 1992 | 36 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2017 | 332 | 0.050 |
Why?
|
| Carbon Dioxide | 1 | 2000 | 78 | 0.050 |
Why?
|
| Raffinose | 2 | 2004 | 28 | 0.040 |
Why?
|
| Creatine Kinase | 1 | 2000 | 46 | 0.040 |
Why?
|
| Platelet Count | 1 | 2000 | 100 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2003 | 307 | 0.040 |
Why?
|
| Antisense Elements (Genetics) | 1 | 1999 | 6 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2000 | 130 | 0.040 |
Why?
|
| Lysosomal Storage Diseases | 1 | 1999 | 6 | 0.040 |
Why?
|
| Epitopes | 1 | 2000 | 146 | 0.040 |
Why?
|
| Glomerular Mesangium | 1 | 1999 | 53 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2005 | 1451 | 0.040 |
Why?
|
| Androstadienes | 1 | 1999 | 41 | 0.040 |
Why?
|
| Cell Division | 2 | 2012 | 541 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 107 | 0.040 |
Why?
|
| Dynamins | 1 | 2018 | 14 | 0.040 |
Why?
|
| omega-N-Methylarginine | 1 | 1998 | 14 | 0.040 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2018 | 10 | 0.040 |
Why?
|
| Behavior Rating Scale | 1 | 2018 | 7 | 0.040 |
Why?
|
| Culture Media, Serum-Free | 1 | 1998 | 35 | 0.040 |
Why?
|
| Apoproteins | 2 | 1989 | 11 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 1998 | 10 | 0.040 |
Why?
|
| Myelin Proteins | 2 | 1989 | 21 | 0.040 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1998 | 6 | 0.040 |
Why?
|
| Okadaic Acid | 1 | 1998 | 22 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2018 | 46 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1998 | 26 | 0.040 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2018 | 51 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 1998 | 24 | 0.040 |
Why?
|
| Peroxisome-Targeting Signal 1 Receptor | 1 | 1998 | 1 | 0.040 |
Why?
|
| Peroxisomal Targeting Signal 2 Receptor | 1 | 1998 | 1 | 0.040 |
Why?
|
| Heme Oxygenase-1 | 1 | 2018 | 40 | 0.040 |
Why?
|
| Isoquinolines | 1 | 1998 | 37 | 0.040 |
Why?
|
| Pyrrolidinones | 1 | 1998 | 15 | 0.040 |
Why?
|
| Caprylates | 2 | 1988 | 32 | 0.040 |
Why?
|
| Amitrole | 2 | 1998 | 4 | 0.040 |
Why?
|
| Protein Sorting Signals | 1 | 1998 | 11 | 0.040 |
Why?
|
| Protein Phosphatase 1 | 1 | 1998 | 36 | 0.040 |
Why?
|
| Nitric Acid | 1 | 1997 | 1 | 0.040 |
Why?
|
| Glutathione Reductase | 1 | 1997 | 17 | 0.040 |
Why?
|
| Mitogens | 1 | 1997 | 45 | 0.040 |
Why?
|
| Diet | 2 | 1993 | 514 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 113 | 0.040 |
Why?
|
| Unconsciousness | 1 | 2017 | 6 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1998 | 82 | 0.040 |
Why?
|
| Sesquiterpenes | 1 | 1997 | 41 | 0.040 |
Why?
|
| Vasospasm, Intracranial | 1 | 2017 | 16 | 0.040 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 1 | 1997 | 2 | 0.040 |
Why?
|
| Antigens | 2 | 2004 | 90 | 0.040 |
Why?
|
| Penicillamine | 1 | 1997 | 10 | 0.040 |
Why?
|
| Epidemiologic Methods | 1 | 2017 | 83 | 0.040 |
Why?
|
| Flavonoids | 1 | 1998 | 109 | 0.040 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2017 | 34 | 0.040 |
Why?
|
| Lung | 2 | 1999 | 849 | 0.040 |
Why?
|
| Intracranial Pressure | 1 | 2017 | 58 | 0.040 |
Why?
|
| Bile Acids and Salts | 1 | 1997 | 19 | 0.040 |
Why?
|
| Enzymes | 1 | 1997 | 25 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2017 | 122 | 0.040 |
Why?
|
| Catalysis | 1 | 1997 | 123 | 0.040 |
Why?
|
| Chromatography, Affinity | 1 | 1996 | 73 | 0.030 |
Why?
|
| Insulin | 2 | 2004 | 619 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1997 | 234 | 0.030 |
Why?
|
| Blood Urea Nitrogen | 1 | 2016 | 65 | 0.030 |
Why?
|
| Protein Stability | 1 | 2016 | 90 | 0.030 |
Why?
|
| Hydroxylation | 1 | 1996 | 41 | 0.030 |
Why?
|
| Drug Combinations | 1 | 1997 | 304 | 0.030 |
Why?
|
| Hybrid Cells | 1 | 1995 | 18 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2015 | 9 | 0.030 |
Why?
|
| Memory | 1 | 2017 | 214 | 0.030 |
Why?
|
| Organomercury Compounds | 1 | 1995 | 1 | 0.030 |
Why?
|
| Carbon Monoxide | 1 | 1995 | 58 | 0.030 |
Why?
|
| Synaptosomes | 1 | 2015 | 57 | 0.030 |
Why?
|
| Protein Conformation | 1 | 1996 | 362 | 0.030 |
Why?
|
| Dextrans | 1 | 1995 | 33 | 0.030 |
Why?
|
| Regional Blood Flow | 2 | 2007 | 168 | 0.030 |
Why?
|
| Fluorescence | 1 | 1995 | 104 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 1996 | 215 | 0.030 |
Why?
|
| Mercury | 1 | 1995 | 34 | 0.030 |
Why?
|
| Species Specificity | 1 | 1995 | 303 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 357 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme Inhibitors | 1 | 1994 | 12 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2015 | 57 | 0.030 |
Why?
|
| Middle Cerebral Artery | 1 | 2015 | 57 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2017 | 295 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 2 | 2006 | 247 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2017 | 418 | 0.030 |
Why?
|
| Acetyl-CoA C-Acyltransferase | 1 | 1994 | 1 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2014 | 59 | 0.030 |
Why?
|
| Centrifugation, Isopycnic | 1 | 1994 | 1 | 0.030 |
Why?
|
| Hypertonic Solutions | 1 | 1994 | 17 | 0.030 |
Why?
|
| Middle Aged | 2 | 2004 | 21147 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 164 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 2 | 2007 | 296 | 0.030 |
Why?
|
| Carbon Radioisotopes | 1 | 1993 | 34 | 0.030 |
Why?
|
| Chromatography, Gas | 1 | 2013 | 31 | 0.030 |
Why?
|
| Cold Temperature | 1 | 1994 | 90 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2013 | 33 | 0.030 |
Why?
|
| PC12 Cells | 2 | 2009 | 36 | 0.030 |
Why?
|
| Receptors, Drug | 1 | 1993 | 31 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 2 | 2003 | 61 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2000 | 3259 | 0.030 |
Why?
|
| Chlorides | 1 | 1993 | 68 | 0.030 |
Why?
|
| Galactosylceramides | 1 | 2013 | 12 | 0.030 |
Why?
|
| Mitochondrial Swelling | 2 | 1992 | 10 | 0.030 |
Why?
|
| Ferric Compounds | 1 | 1993 | 45 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1993 | 72 | 0.030 |
Why?
|
| Mutation | 1 | 1998 | 1213 | 0.030 |
Why?
|
| Dogs | 2 | 2004 | 490 | 0.030 |
Why?
|
| bcl-Associated Death Protein | 1 | 2012 | 19 | 0.030 |
Why?
|
| Animals, Suckling | 1 | 1992 | 7 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 2012 | 15 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2012 | 39 | 0.030 |
Why?
|
| G2 Phase | 1 | 2012 | 26 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2012 | 37 | 0.030 |
Why?
|
| Prognosis | 1 | 2017 | 2093 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 1426 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 1266 | 0.030 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2012 | 29 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2012 | 25 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 261 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1992 | 95 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2012 | 57 | 0.020 |
Why?
|
| Fruit | 1 | 2012 | 86 | 0.020 |
Why?
|
| Adolescent | 1 | 2004 | 8912 | 0.020 |
Why?
|
| Acetyl-CoA C-Acetyltransferase | 1 | 1991 | 2 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 554 | 0.020 |
Why?
|
| Transgenes | 1 | 2011 | 92 | 0.020 |
Why?
|
| Activation Analysis | 1 | 1991 | 1 | 0.020 |
Why?
|
| Mice, Jimpy | 1 | 2010 | 5 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 369 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 2011 | 107 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2010 | 47 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 2010 | 107 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 567 | 0.020 |
Why?
|
| Docosahexaenoic Acids | 1 | 2010 | 12 | 0.020 |
Why?
|
| Bone Development | 1 | 2010 | 37 | 0.020 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1990 | 13 | 0.020 |
Why?
|
| Fluorescence Polarization | 1 | 1990 | 14 | 0.020 |
Why?
|
| Binding Sites, Antibody | 1 | 1990 | 34 | 0.020 |
Why?
|
| Bone Remodeling | 1 | 2010 | 45 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 1990 | 149 | 0.020 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1990 | 81 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 2009 | 31 | 0.020 |
Why?
|
| Myocardium | 1 | 1996 | 1204 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2010 | 93 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1990 | 112 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 110 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2011 | 205 | 0.020 |
Why?
|
| Wallerian Degeneration | 1 | 2009 | 6 | 0.020 |
Why?
|
| Reye Syndrome | 1 | 1989 | 11 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1988 | 57 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 786 | 0.020 |
Why?
|
| Solubility | 1 | 1988 | 134 | 0.020 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1988 | 48 | 0.020 |
Why?
|
| Leukocytes | 1 | 1989 | 99 | 0.020 |
Why?
|
| Homeostasis | 1 | 1990 | 291 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 1988 | 54 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 1990 | 222 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2008 | 282 | 0.020 |
Why?
|
| Calcium | 1 | 1992 | 929 | 0.020 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2008 | 35 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2008 | 114 | 0.020 |
Why?
|
| Tubercidin | 1 | 2007 | 2 | 0.020 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2007 | 11 | 0.020 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 11 | 0.020 |
Why?
|
| G1 Phase | 1 | 2007 | 42 | 0.020 |
Why?
|
| Fetus | 1 | 2007 | 157 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2007 | 111 | 0.020 |
Why?
|
| Nitro Compounds | 1 | 2007 | 11 | 0.020 |
Why?
|
| Terpenes | 1 | 2007 | 18 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2007 | 100 | 0.020 |
Why?
|
| Paralysis | 1 | 2007 | 35 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2007 | 47 | 0.020 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2006 | 9 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2006 | 35 | 0.020 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2007 | 59 | 0.020 |
Why?
|
| Sirolimus | 1 | 2007 | 118 | 0.020 |
Why?
|
| Receptors, Complement 3b | 1 | 2006 | 35 | 0.020 |
Why?
|
| DNA Replication | 1 | 2007 | 167 | 0.020 |
Why?
|
| Group II Phospholipases A2 | 1 | 2006 | 6 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2006 | 77 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2008 | 324 | 0.020 |
Why?
|
| Ethanol | 1 | 1992 | 893 | 0.020 |
Why?
|
| O Antigens | 1 | 2004 | 6 | 0.020 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2004 | 17 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2004 | 47 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 397 | 0.020 |
Why?
|
| Infant | 2 | 2007 | 2891 | 0.020 |
Why?
|
| Cell Count | 1 | 2004 | 248 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2004 | 103 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2004 | 145 | 0.010 |
Why?
|
| Aged | 1 | 2000 | 14862 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 176 | 0.010 |
Why?
|
| Nephrectomy | 1 | 2004 | 103 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 2004 | 107 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 481 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2003 | 6 | 0.010 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2003 | 8 | 0.010 |
Why?
|
| Response Elements | 1 | 2003 | 29 | 0.010 |
Why?
|
| Dehydroepiandrosterone | 1 | 2003 | 29 | 0.010 |
Why?
|
| NADP | 1 | 2003 | 39 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 951 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2003 | 140 | 0.010 |
Why?
|
| Ischemic Preconditioning | 1 | 2002 | 31 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 250 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 191 | 0.010 |
Why?
|
| Probability | 1 | 2003 | 245 | 0.010 |
Why?
|
| Survival Rate | 1 | 2004 | 1056 | 0.010 |
Why?
|
| Graft Survival | 1 | 2004 | 465 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2007 | 3187 | 0.010 |
Why?
|
| Ibuprofen | 1 | 2000 | 30 | 0.010 |
Why?
|
| Catecholamines | 1 | 2000 | 73 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2003 | 384 | 0.010 |
Why?
|
| Kupffer Cells | 1 | 2000 | 75 | 0.010 |
Why?
|
| Common Cold | 1 | 1999 | 8 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1999 | 57 | 0.010 |
Why?
|
| Diamide | 1 | 1998 | 1 | 0.010 |
Why?
|
| Imidazoline Receptors | 1 | 1993 | 8 | 0.010 |
Why?
|
| Photochemistry | 1 | 1993 | 46 | 0.010 |
Why?
|
| Affinity Labels | 1 | 1993 | 66 | 0.010 |
Why?
|
| Salicylic Acid | 1 | 1992 | 4 | 0.010 |
Why?
|
| Cattle | 1 | 1989 | 475 | 0.000 |
Why?
|
| Syndrome | 1 | 1989 | 255 | 0.000 |
Why?
|
| Acylation | 1 | 1986 | 22 | 0.000 |
Why?
|